Back Menu
Human Stem Cells Institute

Human Stem Cells Institute PJSC (HSCI, MOEX: ISKJ) is a Russian public biotech company founded in 2003.

Today, HSCI is a strategic investor with diversified assets in high-growth markets related to the development and introduction of innovative drugs, medical devices, genetic testing & genomic analysis, advanced medical and healthcare services.

HSCI invests in various areas and manages assets at different stages of development (startups, early growth companies, mature companies with positive cash flows and stable margins).

As of now, HSCI is the parent holding company which owns over 10 subsidiaries, including one MOEX issuer (IMCB, ticker: GEMA) and five Skolkovo residents.

The HSCI Group aims to improve quality of life and increase life expectancy by pushing forward personalized, predictive and preventive medicine, as well as integrating recent advances in medical genetics, bioinformatics, gene therapy, cell technologies & tissue engineering, biobanking and biopharmaceutics into clinical practice and healthcare.

Gemabank® was created in 2003 on the base of the Blokhin Cancer Research Center of the Russian Academy of Medical Sciences and was one of the first in Russia to offer cord blood stem cell isolation, cryopreservation and storage service.
Neovasculgen® is the first-in-class gene therapy drug for the treatment of atherosclerotic Peripheral Arterial Disease (PAD), including Critical Limb Ischemia (CLI).
SPRS-therapy (Service for Personal Regeneration of Skin) – a set of personalized diagnostic and treatment procedures for skin restoration with signs of age-related and other structural changes. The service is provided on the basis of registered innovative technology in regenerative and personalized medicine.
Genetico® – a socially significant HSCI project implemented in partnership with the Biofund with the goal of developing personalized medicine in the diagnosis and prevention of hereditary diseases and genetically determined reproductive pathologies.
Reprobank — high-tech cryobank of reproductive cells and tissues, which includes: a modern laboratory, a sperm and oocyte donor bank, a personal bank for storing sperm, embryos, and eggs.